Postoperative New-Onset Atrial Fibrillation following Noncardiac Operations: Prevalence, Complication, and Long-Term MACE
Table 2
Baseline clinical characteristics among study groups.
Parameters
POAF (N = 65)
Control (N = 24060)
value
Age (mean ± range)
63.8 ± 11.5
49.8 ± 18.6
<0.0001
(65; 40–96)
(49; 19–104)
Gender: male
28 (43.1)
10877 (45.2)
0.73
Smoking
15 (23.1)
2170 (9.0)
<0.0001
Hypertension
45 (69.2)
5602 (23.3)
<0.0001
Diabetes mellitus
24 (36.9)
3454 (14.4)
<0.0001
Renal failure
20 (30.8)
1299 (5.4)
<0.0001
Anemia
12 (18.5)
2357 (9.8)
<0.0001
Ischemic heart disease
20 (30.8)
1724 (7.2)
<0.0001
Chronic heart failure
5 (7.7)
143 (0.6)
<0.0001
CVA/TIA
13 (20.0)
574 (2.4)
<0.0001
CHADS2-VASC2
3.78 ± 1.97
1.24 ± 1.33
<0.0001
(3; 0–8)
(1; 0–9)
CVA, cerebrovascular accident; TIA, transient ischemic attack. Defined as serum creatinine level >1.5 mg/dL or estimated GFR <60 ml/L/1.73 m2 using MDRD. Defined as hemoglobin level <9 gram/dL.
